Parigger, L.; Krassnigg, A.; Hetmann, M.; Hofmann, A.; Gruber, K.; Steinkellner, G.; Gruber, C.C.
CavitOmiX Drug Discovery: Engineering Antivirals with Enhanced Spectrum and Reduced Side Effects for Arboviral Diseases. Viruses 2024, 16, 1186.
https://doi.org/10.3390/v16081186
AMA Style
Parigger L, Krassnigg A, Hetmann M, Hofmann A, Gruber K, Steinkellner G, Gruber CC.
CavitOmiX Drug Discovery: Engineering Antivirals with Enhanced Spectrum and Reduced Side Effects for Arboviral Diseases. Viruses. 2024; 16(8):1186.
https://doi.org/10.3390/v16081186
Chicago/Turabian Style
Parigger, Lena, Andreas Krassnigg, Michael Hetmann, Anna Hofmann, Karl Gruber, Georg Steinkellner, and Christian C. Gruber.
2024. "CavitOmiX Drug Discovery: Engineering Antivirals with Enhanced Spectrum and Reduced Side Effects for Arboviral Diseases" Viruses 16, no. 8: 1186.
https://doi.org/10.3390/v16081186
APA Style
Parigger, L., Krassnigg, A., Hetmann, M., Hofmann, A., Gruber, K., Steinkellner, G., & Gruber, C. C.
(2024). CavitOmiX Drug Discovery: Engineering Antivirals with Enhanced Spectrum and Reduced Side Effects for Arboviral Diseases. Viruses, 16(8), 1186.
https://doi.org/10.3390/v16081186